Spray Drying for Bioavailability Enhancement
Summary: The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. Nearly 40% of the new chemical entities (NCEs) screened by pharmaceutical companies fail to progress to later stages of development due to poor aqueous solubility.1 This eBook explores the factors to consider when determining when spray drying is the right technology for bioavailability enhancement. Experts provide key insights about of the optimization of process parameters and what could go wrong if not executed correctly. Additionally, considerations for when selecting an outsourcing partner are shared.